Alexander Shulgin (1925-06-17–2014-06-02): Pioneering biochemist known | 2Day Wiki

Alexander Shulgin (1925-06-17–2014-06-02) — Pioneering biochemist known for synthesizing and exploring over 200 psychoactive compounds. Explore chronological milestones, 3-act biography, and historical legacy on 2Day Wiki.

Alexander Shulgin (1925-06-17–2014-06-02): Pioneering biochemist known | 2Day Wiki

Alexander Shulgin

Pioneering biochemist known for synthesizing and exploring over 200 psychoactive compounds.

Chronology: 1925-06-17 – 2014-06-02

Origins & Early Life

Alexander Theodore "Sasha" Shulgin (June 17, 1925 – June 2, 2014) was an American biochemist who synthesized and tested over 200 psychedelic and related chemical compounds. Among the most notable psychedelic and related drugs that Shulgin developed include 2C-B, DOM (STP), and Ariadne (4C-D; BL-3912; Dimoxamine). In addition, he is known for discovering and describing the unique effects of the entactogen MDMA (ecstasy), which led to its use in MDMA-assisted psychotherapy and to its widespread use as a recreational drug, for instance in the rave scene. Shulgin studied chemistry at Harvard University and the University of California, Berkeley and received his Ph.D.

Pivotal Works & Achievements

in biochemistry in 1955. He developed the best-selling biodegradable pesticide mexacarbate (Zectran) while working at Dow Chemical Company in the early 1960s. Shulgin became interested in psychedelic chemistry after having his first psychedelic experience in 1960 and from then on began developing new psychedelic compounds in his lab at his home in Lafayette, California. His approach was to synthesize the compounds, test them on himself and a small group of trusted others, and document his findings. He formally published on...

Enduring Legacy & Impact

The historical impact and works continue to influence the modern world.

Contemporary Figures & Related Historical Timelines

Source: Wikipedia